BioCentury | Oct 29, 2012
Company News

Celogos, Clean Cells, Laboratoire francais gene/cell therapy news

...by the CellforCure S.A.S subsidiary of LFB, includes two biotechs and public sector groups: France's Etablissement Francais du Sang...
BioCentury | Jul 9, 2012
Company News

Theradiag board of directors update

...Marne La Vallee, France Business: Diagnostic Appointed: Gerard Tobelem as chairman, formerly chief executive of Etablissement Francais du Sang...
BioCentury | Mar 14, 2011
Company News

Cellectis, EFS deal

...Cellectis and Etablissement Francais du Sang (EFS), the national transfusion service in France, partnered to develop and commercialize red...
...small and medium-sized enterprises (SMEs). Further terms were not disclosed. Cellectis S.A. (Euronext:ALCLS), Romainville, France Etablissement Francais du Sang...
BioCentury | Feb 15, 2010
Company News

Cerus, EFS deal

...inactivate blood-borne pathogens in red blood cells intended for transfusion. Cerus Corp. (NASDAQ:CERS), Concord, Calif. Etablissement Francais du Sang...
BioCentury | Mar 12, 2001
Finance

Ebb & Flow

This Wednesday marks the one-year anniversary of the biotech meltdown prompted by the Clinton-Blair comments about the patentability of genetic information. Coincidentally, the NASDAQ Composite also began its precipitous slide that month, and if it's...
BioCentury | Mar 12, 2001
Finance

Ebb & Flow

This Wednesday marks the one-year anniversary of the biotech meltdown prompted by the Clinton-Blair comments about the patentability of genetic information. Coincidentally, the NASDAQ Composite also began its precipitous slide that month, and if it's...
BioCentury | Mar 12, 2001
Company News

Modex, The Blood Transfusion Center deal

MDXN acquired exclusive global rights from the center to the use of fibrin glue-keratinocyte combinations for the treatment of wounds. Etablissement Français du Sang, which owns the Blood Transfusion Center, retains non-exclusive rights in France....
Items per page:
1 - 7 of 7
BioCentury | Oct 29, 2012
Company News

Celogos, Clean Cells, Laboratoire francais gene/cell therapy news

...by the CellforCure S.A.S subsidiary of LFB, includes two biotechs and public sector groups: France's Etablissement Francais du Sang...
BioCentury | Jul 9, 2012
Company News

Theradiag board of directors update

...Marne La Vallee, France Business: Diagnostic Appointed: Gerard Tobelem as chairman, formerly chief executive of Etablissement Francais du Sang...
BioCentury | Mar 14, 2011
Company News

Cellectis, EFS deal

...Cellectis and Etablissement Francais du Sang (EFS), the national transfusion service in France, partnered to develop and commercialize red...
...small and medium-sized enterprises (SMEs). Further terms were not disclosed. Cellectis S.A. (Euronext:ALCLS), Romainville, France Etablissement Francais du Sang...
BioCentury | Feb 15, 2010
Company News

Cerus, EFS deal

...inactivate blood-borne pathogens in red blood cells intended for transfusion. Cerus Corp. (NASDAQ:CERS), Concord, Calif. Etablissement Francais du Sang...
BioCentury | Mar 12, 2001
Finance

Ebb & Flow

This Wednesday marks the one-year anniversary of the biotech meltdown prompted by the Clinton-Blair comments about the patentability of genetic information. Coincidentally, the NASDAQ Composite also began its precipitous slide that month, and if it's...
BioCentury | Mar 12, 2001
Finance

Ebb & Flow

This Wednesday marks the one-year anniversary of the biotech meltdown prompted by the Clinton-Blair comments about the patentability of genetic information. Coincidentally, the NASDAQ Composite also began its precipitous slide that month, and if it's...
BioCentury | Mar 12, 2001
Company News

Modex, The Blood Transfusion Center deal

MDXN acquired exclusive global rights from the center to the use of fibrin glue-keratinocyte combinations for the treatment of wounds. Etablissement Français du Sang, which owns the Blood Transfusion Center, retains non-exclusive rights in France....
Items per page:
1 - 7 of 7